Boston Scientific
855 hedge funds and large institutions have $58B invested in Boston Scientific in 2019 Q4 according to their latest regulatory filings, with 147 funds opening new positions, 301 increasing their positions, 276 reducing their positions, and 57 closing their positions.
158% more first-time investments, than exits
New positions opened: 147 | Existing positions closed: 57
123% more funds holding in top 10
Funds holding in top 10: 13 → 29 (+16)
11% more funds holding
Funds holding: 771 → 855 (+84)
9% more repeat investments, than reductions
Existing positions increased: 301 | Existing positions reduced: 276
6% more call options, than puts
Call options by funds: $188M | Put options by funds: $176M
0.19% less ownership
Funds ownership: 92.27% → 92.08% (-0.19%)
2% less capital inflows, than outflows
Capital inflows: $2.73B | Capital outflows: $2.78B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$399M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$338M |
| 3 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$199M |
| 4 |
DSM Capital Partners
Palm Beach Gardens,
Florida
|
+$95.5M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
+$70.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$723M |
| 2 |
BlackRock
New York
|
-$444M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$220M |
| 4 |
JP Morgan Chase
New York
|
-$94.3M |
| 5 |
Fred Alger Management
New York
|
-$90.1M |
BSX Hedge Fund Activity: Q4 2019 in Review
855 of the 5,090 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2019, worth a combined $58B — up 11% from $52.3B a quarter earlier.
Buyers outnumbered sellers: 147 funds opened new BSX positions and 57 closed out — a net gain of 90 holders — while 301 added to existing stakes and 276 trimmed.
The largest buyer was Jennison Associates, adding an estimated $399M. The largest seller was Wellington Management Group, cutting an estimated $723M.
- 855 institutional investors held Boston Scientific (BSX) as of Q4 2019, up from 771 in Q3 2019.
- Funds reported $58B of Boston Scientific stock for Q4 2019, up 11% quarter-over-quarter.
- 147 funds opened new Boston Scientific positions in Q4 2019 and 57 closed out, a net change of +90 holders.
- The largest Boston Scientific buyer in Q4 2019 was Jennison Associates, an estimated $399M added.
- The largest Boston Scientific seller in Q4 2019 was Wellington Management Group, an estimated $723M sold.
Based on aggregated 13F filings for Q4 2019.